Interaction of caveolin-1, nitric oxide, and nitric oxide synthases in hypoxic human SK-N-MC neuroblastoma cells

Journal of Neurochemistry

Volumn 107, Issue 2, 2008, Pages 478-487

  Shen, Jiangang ^a,b   Lee, Waisin ^a   Li, Yue ^a   Lau, Chi Fai ^b   Ng, Kwong Man ^b   Fung, Man Lung ^b   Liu, Ke Jian ^c  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Caveolin 1; Hypoxia; Neuroblastoma cells; Nitric oxide; Nitric oxide synthases

Indexed keywords

CAVEOLIN 1; CAVEOLIN 2; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; HYPOXIA; NEUROBLASTOMA CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

ANALYSIS OF VARIANCE; ANNEXIN A5; CAVEOLIN 1; CAVEOLIN 2; CELL HYPOXIA; CELL LINE, TUMOR; DEET; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HUMANS; NEUROBLASTOMA; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RNA, MESSENGER; TIME FACTORS; TRANSFECTION;

EID: 53149114868     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05630.x     Document Type: Article

References (44)

1. Arvanitis D. N., Wang H., Bagshaw R. D., Callahan J. W. Boggs J. M. (2004) Membrane-associated estrogen receptor and caveolin-1 are present in central nervous system myelin and oligodendrocyte plasma membranes. J. Neurosci. Res. 75, 603 613.
2. Bu J., Bruckner S. R., Sengoku T., Geddes J. W. Estus S. (2003) Glutamate regulates caveolin expression in rat hippocampal neurons. J. Neurosci. Res. 72, 185 190.
3. Bucci M., Gratton J. P., Rudic R. D., Acevedo L., Roviezzo F., Cirino G. Sessa W. C. (2000) In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat. Med. 6, 1362 1367.
4. van Engeland M., Nieland L. J., Ramaekers F. C., Schutte B. Reutelingsperger C. P. (1998) Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31, 1 9.
5. Everson W. V. Smart E. J. (2001) Influence of caveolin, cholesterol, and lipoproteins on nitric oxide synthase: implications for vascular disease. Trends Cardiovasc. Med. 11, 246 250.
6. Felley-Bosco E., Bender F. C., Courjault-Gautier F., Bron C. Quest A. F. (2000) Caveolin-1 down-regulates inducible nitric oxide synthase via the proteasome pathway in human colon carcinoma cells. Proc. Natl Acad. Sci. USA 97, 14334 14339.
7. Feron O., Belhassen L., Kobzik L., Smith T. W., Kelly R. A. Michel T. (1996) Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J. Biol. Chem. 271, 22810 22814.
8. Fielding C. J. Fielding P. E. (2001) Caveolae and intracellular trafficking of cholesterol. Adv. Drug. Deliv. Rev. 49, 251 264.
9. Fredlund E., Ovenberger M., Borg K. Påhlman S. (2008) Transcriptional adaptation of neuroblastoma cells to hypoxia. Biochem. Biophys. Res. Commun. 366, 1054 1060.
10. Galbiati F., Volonte D., Gil O. et al. (1998) Expression of caveolin-1 and -2 in differentiating PC12 cells and dorsal root ganglion neurons: caveolin-2 is up-regulated in response to cell injury. Proc. Natl Acad. Sci. USA 95, 10257 10262.
11. Garcia-Cardena G., Martasek P., Masters B. S., Skidd P. M., Couet J., Li S., Lisanti M. P. Sessa W. C. (1997) Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the NOS caveolin binding domain in vivo. J. Biol. Chem. 272, 25437 25440.
12. Goligorsky M. S., Li H., Brodsky S. Chen J. (2002) Relationships between caveolae and eNOS: everything in proximity and the proximity of everything. Am. J. Physiol. Renal Physiol. 283, F1 F10.
13. Gratton J. P., Fontana J., O'Connor D. S., Garcia-Cardena G., McCabe T. J. Sessa W. C. (2000) Reconstitution of an endothelial nitric-oxide synthase (eNOS), hsp90, and caveolin-1 complex in vitro. Evidence that hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1. J. Biol. Chem. 275, 22268 22272.
14. van Heerde W. L., Robert-Offerman S., Dumont E., Hofstra L., Doevendans P. A., Smits J. F., Daemen M. J. Reutelingsperger C. P. (2000) Markers of apoptosis in cardiovascular tissues: focus on Annexin V. Cardiovasc. Res. 45, 549 559.
15. Ikezu T., Ueda H., Trapp B. D. et al. (1998) Affinity-purification and characterization of caveolins from the brain: differential expression of caveolin-1, -2, and -3 in brain endothelial and astroglial cell types. Brain Res. 804, 177 192.
16. Itoh Y., Ma F. H., Hoshi H., Oka M., Noda K., Ukai Y., Kojima H., Nagano T. Toda N. (2000) Determination and bioimaging method for nitric oxide in biological specimens by diaminofluorescein fluorometry. Anal. Biochem. 287, 203 209.
17. Jasmin J. F., Malhotra S., Singh Dhallu M., Mercier I., Rosenbaum D. M. Lisanti M. P. (2007) Caveolin-1 deficiency increases cerebral ischemic injury. Circ. Res. 100, 721 729.
18. John T. A., Ibe B. O. Usha Raj J. (2006) Oxygen alters caveolin-1 and nitric oxide synthase-3 functions in ovine fetal and neonatal lung microvascular endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 291, L1079 L1093.
19. Ju H., Zou R., Venema V. J. Venema R. C. (1997) Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J. Biol. Chem. 272, 18522 18525.
20. Kasim N., Branton R. L. Clarke D. J. (2001) Neuronal nitric oxide synthase immunohistochemistry and 4,5-diaminofluorescein diacetate: tools for nitric oxide research. J. Neurosci. Methods 112, 1 8.
21. -ΔΔCt method. Methods 25, 402 408.
22. Kojima H., Nakatsubo N., Kikuchi K., Kawahara S., Kirino Y., Nagoshi H., Hirata Y. Nagano T. (1998a) Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal. Chem. 70, 2446 2453.
23. Kojima H., Nakatsubo N., Kikuchi K., Urano Y., Higuchi T., Tanaka J., Kudo Y. Nagano T. (1998b) Direct evidence of NO production in rat hippocampus and cortex using a new fluorescent indicator: DAF-2 DA. Neuroreport 9, 3345 3348.
24. Li H., Brodsky S., Basco M., Romanov V., De Angelis D. A. Goligorsky M. S. (2001) Nitric oxide attenuates signal transduction: possible role in dissociating caveolin-1 scaffold. Circ. Res. 88, 229 236.
25. Mathew R., Huang J. Gewitz M. H. (2007) Pulmonary artery hypertension: caveolin-1 and eNOS interrelationship: a new perspective. Cardiol Rev. 15, 143 149.
26. Mikol D. D., Scherer S. S., Duckett S. J., Hong H. L. Feldman E. L. (2002) Schwann cell caveolin-1 expression increases during myelination and decreases after axotomy. Glia 38, 191 199.
27. Mukhopadhyay S., Xu F. Sehgal P. B. (2007) Aberrant cytoplasmic sequestration of eNOS in endothelial cells after monocrotaline, hypoxia, and senescence: live-cell caveolar and cytoplasmic NO imaging. Am. J. Physiol. Heart Circ. Physiol. 292, H1373 H1389.
28. Murata T., Sato K., Hori M., Ozaki H. Karaki H. (2002) Decreased endothelial nitric-oxide synthase (eNOS) activity resulting from abnormal interaction between eNOS and its regulatory proteins in hypoxia-induced pulmonary hypertension. J. Biol. Chem. 277, 44085 44092.
29. Nusbaum P., Lainé C., Seveau S., Lesavre P. Halbwachs-Mecarelli L. (2004) Early membrane events in polymorphonuclear cell (PMN) apoptosis: membrane blebbing and vesicle release, CD43 and CD16 down-regulation and phosphatidylserine externalization. Biochem. Soc. Trans. 32, 477 479.
30. Ratajczak P., Damy T., Heymes C., Oliviero P., Marotte F., Robidel E., Sercombe R., Boczkowski J., Rappaport L. Samuel J. L. (2003) Caveolin-1 and -3 dissociations from caveolae to cytosol in the heart during aging and after myocardial infarction in rat. Cardiovasc. Res. 57, 358 369.
31. Razani B., Engelman J. A., Wang X. B. et al. (2001) Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J. Biol. Chem. 276, 38121 38138.
32. Sato Y., Sagami I. Shimizu T. (2004) Identification of caveolin-1-interacting sites in neuronal nitric-oxide synthase. Molecular mechanism for inhibition of NO formation. J. Biol. Chem. 279, 8827 8836.
33. Scherer P. E., Lewis R. Y., Volonte D., Engelman J. A., Galbiati F., Couet J., Kohtz D. S., van Donselaar E., Peters P. Lisanti M. P. (1997) Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J. Biol. Chem. 272, 29337 29346.
34. Semenza G. L. (2003) Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 721 732.
35. Shen J. G., Quo X. S., Jiang B., Li M., Xin W. Zhao B. L. (2000) Chinonin, a novel drug against cardiomyocyte apoptosis induced by hypoxia and reoxygenation. Biochim. Biophys. Acta 1500, 217 226.
36. Shen J. G., Ma S., Chan C. P., Fung P. C., Cheung R. T. F. Liu K. J. (2006) Nitric oxide down-regulates caveolin-1 expression in rat brains during focal cerebral ischemia and reperfusion. J. Neurochem. 96, 1078 1089.
37. Song K. S., Scherer P. E., Tang Z., Okamoto T., Li S., Chafel M., Chu C., Kohtz D. S. Lisanti M. P. (1996) Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J. Biol. Chem. 271, 15160 15165.
38. 2+ channels by S-nitrosylation in rat hippocampal neurons during severe hypoxia and in vitro ischemia. Free Radic. Biol. Med. 42, 52 63.
39. Tjong Y. W., Li M., Hung M. W., Wang K. Fung M. L. (2008) Nitric oxide deficit in chronic intermittent hypoxia impairs large conductance calcium-activated potassium channel activity in rat hippocampal neurons. Free Radic. Biol. Med. 44, 547 557.
40. Venema V. J., Ju H., Zou R. Venema R. C. (1997) Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain. J. Biol. Chem. 272, 28187 28190.
41. Woodman S. E., Sotgia F., Galbiati F., Minetti C. Lisanti M. P. (2004) Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases. Neurology 62, 538 543.
42. Ye J. S., Tipoe G. L., Fung P. C. Fung M. L. (2002) Augmentation of hypoxia-induced nitric oxide generation in the rat carotid body adapted to chronic hypoxia: an involvement of constitutive and inducible nitric oxide synthases. Pflugers Arch. 444, 178 185.
43. Young L. H., Ikeda Y. Lefer A. M. (2001) Caveolin-1 peptide exerts cardioprotective effects in myocardial ischemia-reperfusion via nitric oxide mechanism. Am. J. Physiol. Heart Circ. Physiol. 280, H2489 H2495.
44. Zschocke J., Manthey D., Bayatti N., van der Burg B., Goodenough S. Behl C. (2002) Estrogen receptor alpha-mediated silencing of caveolin gene expression in neuronal cells. J. Biol. Chem. 277, 38772 38780.